-
Citi Reiterates Buy on Bristol Myers Squibb, Raises PT to $39
Tuesday, August 2, 2011 - 7:33am | 61Citi reiterated its Buy rating on Bristol Myers Squibb (NYSE: BMY). At the same time, the rating agency raised its price target on the company's stock from $30 to $39. On Monday, BMY lost 0.38% of its value to finish the day at $28.55. Its shares continued to slide in today's pre-market trading,...
-
A Peek Into The Market Before The Trading Starts
Tuesday, August 2, 2011 - 7:31am | 353Pre-open movers US stock futures are lower this morning. Futures for the Dow Jones Industrial Average dipped 51 points to 11,989.00 and S&P 500 index futures fell 6.70 points to 1,273.00. Nasdaq 100 futures dropped 11.25 points to 2,334.75. A Peek Into Global Markets European markets were...
-
UPDATE: Pfizer Reports Rise In Q2 Profit, Backs 2011 Forecast
Tuesday, August 2, 2011 - 7:27am | 104Pfizer Inc (NYSE: PFE) released its results for the second quarter on Tuesday. Pfizer's quarterly profit surged to $2.61 billion, or $0.33 per share, from $2.48 billion, or $0.31 per share, in the year-earlier period. Its adjusted profit came in at $0.60 per share. Pfizer's revenue declined to $...
-
Morgan Stanley Lowers PT On Auxilium Pharmaceuticals To $18
Tuesday, August 2, 2011 - 7:23am | 27Morgan Stanley has lowered the price target on Auxilium Pharmaceuticals (NASDAQ: AUXL) from $26 to $18 and maintains its Equal-weight rating.
-
Akorn to Acquire a Minority Stake in Aciex Therapeutics
Tuesday, August 2, 2011 - 7:23am | 86Akorn, Inc. (NASDAQ: AKRX) today announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat ocular diseases. Aciex's pipeline...
-
MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
Tuesday, August 2, 2011 - 7:05am | 152MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA), with a goal date of March 26,...
-
Teva Receives European Marketing Authorization for ZOELY™ Oral Contraceptive
Tuesday, August 2, 2011 - 6:55am | 133Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) announced today that its new oral contraceptive, ZOELY™ (NOMAC/E2 –nomegestrol acetate 2.5 mg/17β-estradiol 1.5 mg), has received a Marketing Authorization in the European Union (EU) for the prevention of pregnancy. This clears the way to allow the...
-
US Stock Futures Signal Lower Start On Wall Street
Tuesday, August 2, 2011 - 6:29am | 518US stock futures are lower this morning. Futures for the Dow Jones Industrial Average dipped 49 points to 11,991.00 and S&P 500 index futures fell 6.50 points to 1,273.20. Nasdaq 100 futures dropped 10.25 points to 2,335.75. US stocks closed lower on Monday, with the Dow Jones Industrial...
-
Citigroup Raises PT On Bristol-Myers Squibb To $39
Tuesday, August 2, 2011 - 6:07am | 26Citigroup has raised the price target on Bristol-Myers Squibb (NYSE: BMY) from $30 to $39 and maintains its Buy rating.
-
Stocks to Watch for Tuesday 8/02/2011: Fresh 52-Week Highs and Lows
Tuesday, August 2, 2011 - 4:20am | 3164Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and exit/entry points become more clearly defined. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to...
-
Earnings Scheduled For August 2
Tuesday, August 2, 2011 - 3:46am | 571Hyatt Hotels Corporation (NYSE: H) is expected to report its Q2 EPS at $0.15 on revenue of $910.14 million. Archer-Daniels-Midland Company (NYSE: ADM) is projected to report its FQ4 EPS at $0.85 on revenue of $20.43 billion. Coach Inc (NYSE: COH) is projected to report its Q4 EPS at $0.65 on...
-
Stocks To Watch For August 2
Tuesday, August 2, 2011 - 3:02am | 240Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc (NYSE: PFE) to report its Q2 EPS at $0.59 on revenue of $16.98 billion. Pfizer shares gained 1.21% to $19.24 in after-hours trading. FMC Corp (NYSE: FMC) reported its Q2 profit at $107.2 million, or $1.49...
-
ETFs To Watch August 2, 2011
Monday, August 1, 2011 - 7:39pm | 222Here is the ETF Professor's ETF Watch List for Tuesday August 2, 2011. Play earnings from Pfizer (NYSE: PFE) with the Pharmaceutical HOLDRs (AMEX: PPH) and the Health Care Select Sector SPDR (NYSE: XLV). Ag stocks continue hold up relatively well, so give the Market Vectors Agribusiness ETF (NYSE...
-
Jefferies Comments on Forest Labs
Monday, August 1, 2011 - 3:45pm | 130Jefferies provided color on Forest Labs (NYSE: FRX) in a research report published today. Jefferies has previously given Forest Labs a Buy rating and $46 price target. In the report, Jefferies states, "We think most people have missed the fact that in its SEC filing on Friday and its letter to...
-
UPDATE: Citi Lowering Price Target On Auxilium Pharmaceuticals
Monday, August 1, 2011 - 3:36pm | 115Citi Investment Research is out with a research report on Auxilium Pharmaceuticals Inc (NASDAQ: AUXL) and is lowering its price to $22 from $27. It has a Hold rating on shares. In a note to clients, Citi Investment Research writes, "We are decreasing our PT to $22. In our view Street expectations...